MindSens

About

Rapid, accessible screening for Alzheimer’s Disease Dementia

MindSens offers an innovative, user-friendly blood-based screening device for early detection of Alzheimer’s Disease Dementia (ADD). Designed for home use, it detects biomarkers of brain neuronal damage, providing results in just 15 minutes. This device eliminates the need for costly and invasive methods like MRI or cerebrospinal fluid analysis, enabling regular monitoring by non-specialists. MindSens aims to improve early diagnosis and intervention, reducing the long-term economic and healthcare burden of ADD while enhancing patient outcomes

Team

Saffan Firdaus
Imperial College London Royal College of Art
I am a multidisciplinary designer specializing in product design and engineering, currently pursuing a master's in Innovation Design Engineering at Imperial College London and the Royal College of Art.more
Portfolio LinkedIn
Rica Asrosa
University College London
Rica Asrosa is an interdisciplinary researcher specializing in Advanced Materials Science and Biosensing. As a co-founder of MindSens, she focuses on developing innovative biosensors and medical devices for healthcare applications, including diabetes, kidney disease, and dementia. With a passion for education and research, Rica aims to translate scientific discoveries into practical solutions that enhance patient care. Her work bridges the gap between laboratory research and real-world healthcare, significantly advancing personalized and preventive medical technologies.more